Hydromorphone HCL 25 mg/ml recalled over sterility concerns
- Recall date
- February 4, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hartley Medical Center Pharmacy, Incorporated recalls Hydromorphone HCL 25 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA
- Recall number
- D-0750-2016
- FDA classification
- Class II
- Brand / firm
- Hartley Medical Center Pharmacy, Incorporated
- Sold / distributed
- Nationwide. No foreign distribution.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Hydromorphone HCL 25 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA
Get recall alerts
Free email alert whenever Hartley Medical Center Pharmacy, Incorporated has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hartley Medical Center Pharmacy, Incorporated